Weiguo Ye - 07 Mar 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Chief Operating Officer
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Weiguo Ye
Issuer symbol
GYRE
Transactions as of
07 Mar 2025
Transactions value $
$0
Form type
4
Filing time
11 Mar 2025, 20:00:30 UTC
Previous filing
22 Nov 2023
Next filing
25 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +300K $0.00 300K 07 Mar 2025 Common Stock 300K $10.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 300,000 shares of the Issuer's common stock and will vest in 48 equal monthly installments through March 7, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date.